Simpson Manufacturing Reports Q3 2026 Results, Updates Guidance
Net sales rose 2.3% year over year to $638.1 million, with a 22.1% operating margin. The company updated its full-year 2026 guidance.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Net sales rose 2.3% year over year to $638.1 million, with a 22.1% operating margin. The company updated its full-year 2026 guidance.
Regenxbio (NASDAQ: RGNX ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Regenxbio reported strong prog